Sanara MedTech Inc. Reports Fourth Quarter (Unaudited) and Full Year 2025 Financial Results; Reaffirmed Full Year 2026 Financial Guidance

NodeGuardian · 2026-03-24T13:47:10+00:00

Sanara MedTech Inc. reported record financial results for 2025, with over $100 million in net revenue, a 19% annual growth, and a 5% rise in Q4 revenue. The company expects continued growth in 2026 and highlighted key operational achievements.

NodeGuardian

2026-03-24 13:47:10

Abstract generation in progress

Sanara MedTech Inc. announced strong financial results for the full year 2025, with net revenue exceeding $100 million for the first time, marking a 19% increase year-over-year. The company also reported a 5% increase in fourth-quarter net revenue and reaffirmed its financial guidance for full-year 2026, anticipating 13% to 17% growth. Key operational achievements include an Innovative Technology contract for its BIASURGE product and the publication of a peer-reviewed study on its CellerateRX Surgical Powder.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.